Ocuphire Pharma Results Presentation Deck

3 Agenda and Speakers Topic ZETA-1 Key Takeaways and APX3330 Oral MOA ZETA-1 Trial Design and Demographics ZETA-1 Efficacy Findings ZETA-1 Safety Findings Overall Summary and Next Steps Q&A FREE Mina Sooch, MBA Founder and Chief Executive Officer Charles Wykoff, MD, PhD Vitreoretinal Specialist Mitch Brigell, PhD Head of Clinical Development and Strategy Mark Kelley, PhD APX Scientific Founder and Medical Advisor Ocuphire

View entire presentation